NCT03601169View on ClinicalTrials.gov

Comparison of MMFS Dosages in Older Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
AnxietyDepressionSleep QualityCognitive Impairment
Interventions
DIETARY_SUPPLEMENT

Low Dose MMFS-205-SR

Twice daily, oral 500mg tablets

DIETARY_SUPPLEMENT

High Dose MMFS-205-SR

Twice daily, oral 500mg tablets

DIETARY_SUPPLEMENT

Placebo

Twice daily, oral

Trial Locations (1)

65802

Bio-Kinetic Clinical Applications, LLC, Springfield

Sponsors

Lead Sponsor

Neurocentria, Inc.
All Listed Sponsors
lead

Neurocentria, Inc.

INDUSTRY

NCT03601169 - Comparison of MMFS Dosages in Older Adults | Biotech Hunter | Biotech Hunter